Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-29

Clinical Trial Update: Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis [Phase 3]

View source ↗

Summary

Phase 3 trial of inhaled mannitol for bronchiectasis completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mannitol (mannitol)

Snippet

Sponsor: Syntara | Conditions: Bronchiectasis | Phase 3 | Status: COMPLETED | Results posted: 2016-04-29